PMC:7283670 / 123806-124017
Annnotations
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T673 | 128-132 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
T674 | 187-191 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T1451 | 56-65 | Chemical | denotes | Lopinavir | http://purl.obolibrary.org/obo/CHEBI_31781 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1030 | 0-211 | Sentence | denotes | Previous studies suggested that when combined together, Lopinavir and Ritonavir act in concert to hinder further replication of SARS‐CoV, and improve the clinical status of patients with SARS (Chu et al., 2004). |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
2524 | 128-136 | Species | denotes | SARS‐CoV | Tax:694009 |
2525 | 173-181 | Species | denotes | patients | Tax:9606 |
2527 | 56-65 | Chemical | denotes | Lopinavir | MESH:D061466 |
2528 | 70-79 | Chemical | denotes | Ritonavir | MESH:D019438 |